Page 35 - BH-2-3
P. 35

Brain & Heart                                                    Digital tools for stroke and bleeding risk in AF




                   Source equations/  evidence on   page?  No  Yes       Yes              No               N/A
             Table 3. Digital tools for estimating stroke and/or bleeding risk in patients with atrial fibrillation (AF), including the comparison of their web applications, mobile




                   Based on what   score?  CHA 2 Ds 2 -VASc  CHADS 2  &   CHA 2 DS 2 -VASc  GARFIELD-AF  CHA 2 DS 2 -VASc     (& Cockcraft-   Gault)  Not Listed





                   Validation of the   digital tool been   done?  Effect on   decision-making   and encounter   length   examined 78,79  Effect on   decision-making   examined 80  Validation of   score (not digital   tool specifically)   published 81  No  No









                   Presence of a   dedicated mobile   application   No  No  Yes, on both iOS and   Android. By QxMD   and MD Calc.  Yes, on both iOS   and Android. By   ACC (available as   “ AnticoagEvaluator”)  No




                   Last update   date   present  No      Yes:   February   2024  No       Yes: 2019        No




                   Intended   user  Both                 Provider        Provider         Provider         Patient




                   Main host of tool and URL  Mayo Clinic  https://  anticoagulationdecisionaid.  mayoclinic.org/index.php/  site/anticoagulation  SPARCtool https://www.sparctool.com/  GARFIELD Registry https://af.garfieldregistry.org/  garfield-af-risk-calculator  ACC  https://tools.acc.org/  anticoag/#!/content/  calculator/  ACC  https://www.cardiosmart.  org/stroke-and-bleeding   -risk-calculator












                   Description   of digital tool   purpose  Generates a   decision-making   report for patients   to be informed   on the best   anticoagulation   option for them by   exploring their risk   of a stroke with an   underlying history   of AF under no   anticoagulation,   being on warfarin,   or being on a   DOAC  Estimates the stroke   risk and presents the   benefits and risks   of antithrombotic   therapy among   chronic   non-valvular AF   patients.  Prov

                applications, and associated evidence  Type of risk Digital tool name  Stroke risk  Anticoagulation   Choice Decision Aid  Both stroke  Stroke Prevention   and bleeding  in Atrial Fibrillation   risk  Both stroke  GARFIELD-AF Risk   and bleeding   risk  Both stroke  ACC Anticoag   and bleeding  Evaluator Application  risk  Both stroke   and bleeding  Atrial Fibrillation   risk and Bleeding Risk










                                                                                                           CardioSmart
                          Mayo Clinic
                                                             Risk Tool




            Volume 2 Issue 3 (2024)                         12  (SPARCtool)  Calculator      doi: 10.36922/bh.3068  Calculator
   30   31   32   33   34   35   36   37   38   39   40